Nnwale COVID-19 ọhụrụ nwere nsonaazụ n'ime sekọnd emepụtara na Canada

Ndị isi Graphene Canada Inc. webatara GLC Medical Inc. ka mepụtara ngwọta Covid-19.
GLC Medical Inc. achọpụtala nnwale nyocha ngwa ngwa (n'okpuru nkeji 1) maka ọnụnọ SARS-CoV-2. Ihe mmetụta enyi na-ejedebe na njedebe na-ewepụ mkpa nke nasopharyngeal swab ka anyị na-eji saliva dị ka ihe nlele. Na-enweghị mkpa nke ọkachamara, ule nyocha a na-ebelata ihe ize ndụ nke mmetọ obe ma na-enye ndị mmadụ udo nke obi na nkasi obi nke ụlọ ha, ma ọ bụ "n'ọnụ ụzọ" nke ebe ntụrụndụ kachasị amasị ha ma ọ bụ ebe ọ bụla chọrọ. nọpụga.

GLCM mezuru mmepe nke ihe mmetụta graphene kwalitere nke ejiri na ngwa nnwale ngwa ngwa, nke bụ in-vitro diagnostic ngwaọrụ nke kit, nke bụ ihe in-vitro ngwaọrụ nyocha nke na-emepụta akara mgbe ekpughere ya na antigens viral COVID-19. Site na mmezu nke njirimara dị mma nke antigens viral, GLCM amalitela mmepe nke ụdị ọrụ nke ule nzaghachi ngwa ngwa. GLCM na-atụ anya irite uru site n'usoro nhazi na nyocha nyocha ụlọ ọgwụ dị ka ọtụtụ ụlọ ọrụ nhazi gụnyere Health Canada na United States'FDA kwupụtara.

 Ndị isi Graphene Canada (GLC) Inc. yana enyemaka GLC Medical (GLCM) Inc. kwuputa mmepe ha nke ihe mmetụta emelitere graphene maka ojiji na nnwale COVID-19 ngwa ngwa na-ebuga nke ọma na ntụkwasị obi. rụpụtara na sekọnd. a ihe mmetụta graphene emelitere na-akwado ngwa ngwa na kacha mfe iji Ngwa nyocha COVID-19 ngwa ngwa na ọ bụ naanị ụdị ule saliva ya, na-ewepụ swab nasopharyngeal, ihe niile ọkachamara na-ahụ maka nlekọta ahụike chọrọ, anaghị achọ ngwá ọrụ dị oke ọnụ, ọ dịghịkwa njikwa cross nke na-abawanye mmetọ cross. Nnwale GLCM na-achọpụta nje a ozugbo na-achọpụta na ọ nweghị nsonaazụ dị mma / adịghị mma, n'adịghị ka ule ndị ọzọ na-achọpụta naanị ihe sitere na ọrịa, yabụ enweghị ntụkwasị obi.

GLCM COVID-19 ule nleba anya ga-enye uru pụrụ iche karịa ule ndị ọzọ ka ọ na-achọpụta ọnụnọ nke nje COVID-19. Ruo ugbu a, ule asọmpi ndị ọzọ ekwuputala bụ nyocha nke acid nucleic na ule edemede serological. Emebere ule nyocha nke serological iji chọpụta ọgwụ mgbochi IgM na IgG dị ugbu a na-efe efe. Nnwale nucleic acid na-achọpụta ọrịa na-arụ ọrụ, Otú ọ dị, ka na-achọ ka a na-eji swab nasopharyngeal na nsonaazụ ga-abụrịrị onye ọkachamara kwadoro na-eji ngwá ọrụ dị oke ọnụ nke na-eme ngwa ngwa. Ma ule serological na nke nucleic na-emepụta nsonaazụ ụgha na nke na-adịghị mma, ebe emepụtara ule GLCM iji gosipụta nsonaazụ dị mma naanị mgbe nje COVID-19 dị, na-enye ohere maka nkọwa doro anya na nke onye ọrụ.

Jason Deacon, Ndupụta Mmepe Ngwaahịa nke GLC-GLCM gosiri, “Graphene bụ ihe nhụta kacha mma. Ọdịdị 2D na àgwà ndị na-eduzi graphene na-eme ka ọ bụrụ ihe na-emetụ n'ahụ iji chọpụta ihe ọ bụla. Achọpụtala m ụkpụrụ a nke ukwuu n'oge m na Mahadum Cambridge. Na GLC-GLCM, anyị emeela ka elu ya dị kpọmkwem maka SARS-CoV-2 (COVID-19) iji hụ na ule ngwa ngwa anyị ga-azọpụta ndụ. A na-etinye ihe ọmụmụ nke ihe 2D na agụmakwụkwọ maka afọ 15. Ndị otu anyị na GLC-GLCM kwenyere na nanotechnology gbasara ihe 2D dị oke mkpa maka teknụzụ na ihe ọhụrụ n'ọdịnihu, yana graphene n'ihu.

Nnwale ngwa ngwa GLCM bụ teknụzụ “n'ọnụ ụzọ” nke zuru oke tupu ịbanye n'ụgbọelu, na-abanye ebe a na-eme egwuregwu ma ọ bụ egwuregwu, ebe ọ na-ewepụta nsonaazụ ozugbo na-enwetaghachi obi ike iji weghachi anyị na “nkịtị” tupu ọrịa a.

Companylọ ọrụ ahụ na-aga n'ihu na mkparịta ụka ya na ndị nrụpụta na gọọmentị n'ọtụtụ mba iji kwado usoro mmepụta ihe na-egosipụta nrube isi nrube isi n'iwu gọọmentị obodo ha.

Donna Mandau, Onye isi ala & CEO nke GLC-GLCM kwuru, "Ọganihu nke mmepe a na-enye ụwa ihe ngwọta maka COVID-19, yana dịka graphene anyị nwere ike ịhazi ya, anyị nwere ike ịnye ngwọta ngwa ngwa maka nje n'ọdịnihu" na mgbanwe ngwa ngwa nke anyị. graphene nke ga-ahụ na anyị agaghị agbakeghachi nnukwu mmechi akụ na ụba dị ka ọ dị na COVID-19. Mkpali maka anyị niile na GLC-GLCM bụ ịnye ngwọta graphene anyị maka Ndị mmadụ na mbara ala. Nnwale ngwa ngwa a na-akpọkọta ezinụlọ na ndị enyi ọnụ maka oge ọṅụ na-enweghị egwu COVID-19. Nnwale a na-ejikọkwa ezinụlọ ọnụ n'oge ndị ahụ anyị kwesịrị ịsị onye anyị hụrụ n'anya nke ọma. Ọ dịghị onye kwesịrị ịnwụ naanị ya ọzọ.”

Graphene Leaders Canada (GLC) Inc. bụ ụlọ ọrụ teknụzụ Canada na-emepụta ihe dị elu, ịdị ọcha graphene nanomaterials nke na-arụ ọrụ dị ka teknụzụ ikpo okwu nwere ikike ịgbakwunye uru n'ofe ọtụtụ ngwa. Ndị isi Graphene Canada Inc. na-elekwasị anya ka ya na ụlọ ọrụ na-arụkọ ọrụ iji mepụta ngwọta site na ijikọta graphene iji mepụta ngwaahịa ọhụrụ.
Ahịrị mkpado GLC bụ “Ime nnukwu ngwaahịa ọbụna ka ukwuu".

GLC Medical (GLCM) Inc. bụ enyemaka nke GLC Inc. ma na-enye ngwọta graphene na ụlọ ọrụ ahụike na-eme ka nkà mmụta sayensị ihe onwunwe anyị na-arụ ọrụ na graphene dị elu na ịmepụta ngwaahịa na ngwọta iji jee ozi ọma nke ndị mmadụ na mbara ala.